Home / Latest Reports / Ophthalmol Drug Market

Ophthalmol Drug Market By Product Type and End-User - Global Industry Analysis And Forecast To 2027

Published On : December 2018 Pages : 150 Category: Pharmaceuticals Report Code : HC122207

SEGMENTS & REGIONS:

  • Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa

Ophthalmol Drug Market By Product Type (Dry eye drugs, Retinal disorders drugs, Glaucoma drugs and Allergic, Inflammatory & Infective drugs); and End-User (Retinal diseases, Glaucoma, Dry eye syndrome and Other ophthalmic indications); - Global Industry Analysis And Forecast To 2027

Category –Pharmaceuticals (Healthcare)                               

Industry Outlook

Ophthalmology is the branch of science that deals with structure, function and disorders related to eyes. Ophthalmol Drug are the drugs used for treatment of eye disorders. The use of Ophthalmol Drug is growing due to; increasing aged population across the globe, increasing cases of eye diseases due to environmental radiation & manmade radiation (monitors, smartphones, etc.), advancement in the drug manufacturing sector, growing awareness amongst the population due to prevailing eye diseases, rising investment by governments across the globe in healthcare sector, etc. Therefore, the Ophthalmol Drug Market is anticipated to expand and has tremendous scope during the forecast period. The global Ophthalmol Drug Market anticipated to flourish in the future by growing at a significantly higher CAGR.

Market Segmentation

The global Ophthalmol Drug Market is based on segment, by Product Type the market is segmented into Dry eye drugs, Retinal disorders drugs, Glaucoma drugs and Allergic, Inflammatory & Infective drugs; and by End-User the market is segmented into Retinal diseases, Glaucoma, Dry eye syndrome and Other ophthalmic indications.

  • Ophthalmol Drug Market, By Product Type
  • Dry eye drugs
  • Retinal disorders drugs
  • Glaucoma drugs
  • Allergic, Inflammatory & Infective drugs
  • Ophthalmol Drug Market, By End-User
  • Retinal diseases
  • Glaucoma
  • Dry eye syndrome
  • Other ophthalmic indications   

Regional Insights

On a global front, the Ophthalmol Drug Market covers North America (United States, Canada and Mexico), Europe (Germany, UK, France, Russia, Italy, Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific), South America (Brazil, Argentina, Columbia, Rest of South America) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA).

Ophthalmol Drug Market, By Region

    • North America
  • U.S.
  • Canada
  • Mexico
    • Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
    • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Southeast Asia
  • Rest of Asia-Pacific
    • South America
  • Brazil
  • Argentina
  • Columbia
  • Rest of South America
    • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Nigeria
  • South Africa
  • Rest of MEA

Competitive Analysis

The leading players in the market are Akorn, Roche, Regeneron, Novartis, Senju, Allergan, Valeant, Pfizer, Bayer and Santen. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.

  • Akorn 
  • Roche
  • Regeneron
  • Novartis
  • Senju
  • Allergan
  • Valeant
  • Pfizer   
  • Bayer
  • Santen   

Some of the key questions answered by the report are:          

  • What was the market size in 2017 and forecast from 2017 to 2027?
  • What will be the industry market growth from 2017 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

o   Ophthalmol Drug Market, By Product Type, Estimates and Forecast, 2017-2027 ($Million)

o   Dry eye drugs

o   Retinal disorders drugs

o   Glaucoma drugs

o   Allergic, inflammatory and infective drugs

o   Ophthalmol Drug Market, By End-User, Estimates and Forecast, 2017-2027 ($Million)

o   Retinal diseases

o   Glaucoma

o   Dry eye syndrome

o   Other ophthalmic indications   

Ophthalmol Drug Market, By Region, Estimates and Forecast, 2017-2027 ($Million)

o   North America

§  North America Ophthalmol Drug Market, By Country

o   U.S. Ophthalmol Drug Market

o   Canada Ophthalmol Drug Market

o   Mexico Ophthalmol Drug Market

o   Europe

§  Europe Ophthalmol Drug Market, By Country

o   Germany Ophthalmol Drug Market

o   UK Ophthalmol Drug Market

o   France Ophthalmol Drug Market

o   Russia Ophthalmol Drug Market

o   Italy Ophthalmol Drug Market

o   Rest of Europe Ophthalmol Drug Market

o   Asia-Pacific

§  Asia-Pacific Ophthalmol Drug Market, By Country

o   China Ophthalmol Drug Market

o   Japan Ophthalmol Drug Market

o   South Korea  Ophthalmol Drug Market

o   India Ophthalmol Drug Market

o   Southeast Asia Ophthalmol Drug Market

o   Rest of Asia-Pacific Ophthalmol Drug Market

o   South America

§  South America Ophthalmol Drug Market, By Country

o   Brazil Ophthalmol Drug Market

o   Argentina Ophthalmol Drug Market

o   Columbia Ophthalmol Drug Market

o   Rest of South America Ophthalmol Drug Market

o   Middle East and Africa

§  Middle East and Africa Ophthalmol Drug Market, By Country

o   Saudi Arabia Ophthalmol Drug Market

o   UAE Ophthalmol Drug Market

o   Egypt Ophthalmol Drug Market

o   Nigeria Ophthalmol Drug Market

o   South Africa Ophthalmol Drug Market

o   Rest of MEA Ophthalmol Drug Market

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

3.3.     SWOT Analysis

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2017-2027)

4.1.2.  Canada Market Status and Outlook (2017-2027)

4.1.3.  Mexico Market Status and Outlook (2017-2027)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2017-2027)

4.2.2.  France Market Status and Outlook (2017-2027)

4.2.3.  UK Market Status and Outlook (2017-2027)

4.2.4.  Russia Market Status and Outlook (2017-2027)

4.2.5.  Italy Market Status and Outlook (2017-2027)

4.2.6.  Rest of Europe Market Status and Outlook (2017-2027)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2017-2027)

4.3.2.  Japan Market Status and Outlook (2017-2027)

4.3.3.  Korea Market Status and Outlook (2017-2027)

4.3.4.  India Market Status and Outlook (2017-2027)

4.3.5.  Southeast Asia Market Status and Outlook (2017-2027)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2017-2027)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2017-2027)

4.4.2.  Argentina Market Status and Outlook (2017-2027)

4.4.3.  Columbia Market Status and Outlook (2017-2027)

4.4.4.  Rest of South America Market Status and Outlook (2017-2027)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2017-2027)

4.5.2.  United Arab Emirates Market Status and Outlook (2017-2027)

4.5.3.  Egypt Market Status and Outlook (2017-2027)

4.5.4.  Nigeria Market Status and Outlook (2017-2027)

4.5.5.  South Africa Market Status and Outlook (2017-2027)

4.5.6.  Turkey Market Status and Outlook (2017-2027)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2017-2027)

5.       Ophthalmol Drug Market, By Ophthalmol Drug

5.1.     Introduction

5.2.     Global Ophthalmol Drug Revenue and Market Share by Ophthalmol Drug (2017-2027)

5.2.1.  Global Ophthalmol Drug Revenue and Revenue Share by Ophthalmol Drug (2017-2027)

5.3.     Dry eye drugs

5.3.1.  Global Dry eye drugs Revenue and Growth Rate (2017-2027)

5.4.     Retinal disorders drugs

5.4.1.  Global Retinal disorders drugs Revenue and Growth Rate (2017-2027)

5.5.     Glaucoma drugs and Allergic

5.5.1.  Global Glaucoma drugs and Allergic Revenue and Growth Rate (2017-2027)

5.6.     Inflammatory & Infective drugs

5.6.1.  Global Inflammatory & Infective drugs Revenue and Growth Rate (2017-2027)

6.       Ophthalmol Drug Market, By End-User

6.1.     Introduction

6.2.     Global Ophthalmol Drug Revenue and Market Share by End-User  (2017-2027)

6.2.1.  Global Ophthalmol Drug Revenue and Revenue Share by End-User  (2017-2027)

6.3.     Retinal diseases

6.3.1.  Global Retinal diseases Revenue and Growth Rate (2017-2027)

6.4.     Glaucoma

6.4.1.  Global Glaucoma Revenue and Growth Rate (2017-2027)

6.5.     Dry eye syndrome

6.5.1.  Global Dry eye syndrome  Revenue and Growth Rate (2017-2027)

6.6.     Other ophthalmic indications

6.6.1.  Global Other ophthalmic indications Revenue and Growth Rate (2017-2027)

7.       Ophthalmol Drug Market, By Region

7.1.     Introduction

7.2.     Global Ophthalmol Drug Revenue and Market Share by Regions

7.2.1.  Global Ophthalmol Drug Revenue by Regions (2017-2027)

7.3.     North America Ophthalmol Drug by Countries

7.3.1.  North America Ophthalmol Drug Revenue and Growth Rate (2017-2027)

7.3.2.  North America Ophthalmol Drug Revenue (Million USD) by Countries (2017-2027)

7.3.3.  United States

7.3.3.1.  United States Ophthalmol Drug Revenue (Millions USD) and Growth Rate (2017-2027)

7.3.4.  Canada

7.3.4.1.  Canada Ophthalmol Drug Revenue (Millions USD) and Growth Rate (2017-2027)

7.3.5.  Mexico

7.3.5.1.  Mexico Ophthalmol Drug Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.     Europe Ophthalmol Drug by Countries

7.4.1.  Europe Ophthalmol Drug Revenue and Growth Rate (2017-2027)

7.4.2.  Europe Ophthalmol Drug Revenue (Million USD) by Countries (2017-2027)

7.4.3.  Germany

7.4.3.1.  Germany Ophthalmol Drug Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.4.  France

7.4.4.1.  France Ophthalmol Drug Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.5.  UK

7.4.5.1.  UK Ophthalmol Drug Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.6.  Russia

7.4.6.1.  Russia Ophthalmol Drug Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.7.  Italy

7.4.7.1.  Italy Ophthalmol Drug Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.8.  Rest of Europe

7.4.8.1.  Rest of Europe Ophthalmol Drug Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.     Asia-Pacific Ophthalmol Drug by Countries

7.5.1.  Asia-Pacific Ophthalmol Drug Revenue and Growth Rate (2017-2027)

7.5.2.  Asia-Pacific Ophthalmol Drug Revenue (Million USD) by Countries (2017-2027)

7.5.3.  China

7.5.3.1.  China Ophthalmol Drug Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.4.  Japan

7.5.4.1.  Japan Ophthalmol Drug Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.5.  Korea

7.5.5.1.  Korea Ophthalmol Drug Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.6.  India

7.5.6.1.  India Ophthalmol Drug Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.7.  Southeast Asia

7.5.7.1.  Southeast Asia Ophthalmol Drug Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.8.  Rest of Asia-Pacific

7.5.8.1.  Rest of Asia-Pacific Ophthalmol Drug Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.     South America Ophthalmol Drug by Countries

7.6.1.  South America Ophthalmol Drug Revenue and Growth Rate (2017-2027)

7.6.2.  South America Ophthalmol Drug Revenue (Million USD) by Countries (2017-2027)

7.6.3.  Brazil

7.6.3.1.  Brazil Ophthalmol Drug Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.4.  Argentina

7.6.4.1.  Argentina Ophthalmol Drug Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.5.  Columbia

7.6.5.1.  Columbia Ophthalmol Drug Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.6.  Rest of South America

7.6.6.1.  Rest of South America Ophthalmol Drug Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.     Middle East and Africa Ophthalmol Drug by Countries

7.7.1.  Middle East and Africa Ophthalmol Drug Revenue and Growth Rate (2017-2027)

7.7.2.  Middle East and Africa Ophthalmol Drug Revenue (Million USD) by Countries (2017-2027)

7.7.3.  Saudi Arabia

7.7.3.1.  Saudi Arabia Ophthalmol Drug Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.4.  United Arab Emirates

7.7.4.1.  United Arab Emirates Ophthalmol Drug Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.5.  Egypt

7.7.5.1.  Egypt Ophthalmol Drug Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.6.  Nigeria

7.7.6.1.  Nigeria Ophthalmol Drug Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.7.  South Africa

7.7.7.1.  South Africa Ophthalmol Drug Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.8.  Turkey

7.7.8.1.  Turkey Ophthalmol Drug Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.9.  Rest of Middle East and Africa

7.7.9.1.  Rest of Middle East and Africa Ophthalmol Drug Revenue (Millions USD) and Growth Rate (2017-2027)

8.       Company Profiles

8.1.     Akorn 

8.1.1.  Business Overview

8.1.2.   Service Portfolio

8.1.3.  Strategic Developments

8.1.4.   Revenue and Market Share

8.2.     Roche

8.2.1.  Business Overview

8.2.2.   Service Portfolio

8.2.3.  Strategic Developments

8.2.4.   Revenue and Market Share

8.3.     Regeneron

8.3.1.  Business Overview

8.3.2.   Service Portfolio

8.3.3.  Strategic Developments

8.3.4.   Revenue and Market Share

8.4.     Novartis

8.4.1.  Business Overview

8.4.2.   Service Portfolio

8.4.3.  Strategic Developments

8.4.4.   Revenue and Market Share

8.5.     Senju

8.5.1.  Business Overview

8.5.2.   Service Portfolio

8.5.3.  Strategic Developments

8.5.4.   Revenue and Market Share

8.6.     Allergan

8.6.1.  Business Overview

8.6.2.   Service Portfolio

8.6.3.  Strategic Developments

8.6.4.   Revenue and Market Share

8.7.     Valeant

8.7.1.  Business Overview

8.7.2.   Service Portfolio

8.7.3.  Strategic Developments

8.7.4.   Revenue and Market Share

8.8.     Pfizer   

8.8.1.  Business Overview

8.8.2.   Service Portfolio

8.8.3.  Strategic Developments

8.8.4.   Revenue and Market Share

8.9.     Bayer

8.9.1.  Business Overview

8.9.2.   Service Portfolio

8.9.3.  Strategic Developments

8.9.4.   Revenue and Market Share

8.10. Santen   

8.10.1.      Business Overview

8.10.2.       Service Portfolio

8.10.3.      Strategic Developments

8.10.4.       Revenue and Market Share

9.       Global Ophthalmol Drug Market Competition, by Manufacturer

9.1.     Global Ophthalmol Drug Revenue and Market Share by Manufacturer (2017-2017)

9.2.     Global Ophthalmol Drug Price By Region (2017-2017)

9.3.     Top 5 Ophthalmol Drug Manufacturer Market Share

9.4.     Market Competition Trend

10.    Ophthalmol Drug Market Forecast (2017-2027)

10.1. Global Ophthalmol Drug Revenue (Millions USD) and Growth Rate (2017-2027)

10.2. Ophthalmol Drug Market Forecast by Regions (2017-2027)

10.2.1.      North America Ophthalmol Drug Market Forecast (2017-2027)

10.2.1.1. United States Ophthalmol Drug Market Forecast (2017-2027)

10.2.1.2. Canada Ophthalmol Drug Market Forecast (2017-2027)

10.2.1.3. Mexico Ophthalmol Drug Market Forecast (2017-2027)

10.2.2.      Europe Ophthalmol Drug Market Forecast (2017-2027)

10.2.2.1. Germany Ophthalmol Drug Market Forecast (2017-2027)

10.2.2.2. France Ophthalmol Drug Market Forecast (2017-2027)

10.2.2.3. UK Ophthalmol Drug Market Forecast (2017-2027)

10.2.2.4. Russia Ophthalmol Drug Market Forecast (2017-2027)

10.2.2.5. Italy Ophthalmol Drug Market Forecast (2017-2027)

10.2.2.6. Rest of Europe Ophthalmol Drug Market Forecast (2017-2027)

10.2.3.      Asia-Pacific Ophthalmol Drug Market Forecast (2017-2027)

10.2.3.1. China Ophthalmol Drug Market Forecast (2017-2027)

10.2.3.2. Japan Ophthalmol Drug Market Forecast (2017-2027)

10.2.3.3. Korea Ophthalmol Drug Market Forecast (2017-2027)

10.2.3.4. India Ophthalmol Drug Market Forecast (2017-2027)

10.2.3.5. Southeast Asia Ophthalmol Drug Market Forecast (2017-2027)

10.2.3.6. Rest of Asia-Pacific Ophthalmol Drug Market Forecast (2017-2027)

10.2.4.      South America Ophthalmol Drug Market Forecast (2017-2027)

10.2.4.1. Brazil Ophthalmol Drug Market Forecast (2017-2027)

10.2.4.2. Argentina Ophthalmol Drug Market Forecast (2017-2027)

10.2.4.3. Columbia Ophthalmol Drug Market Forecast (2017-2027)

10.2.4.4. Rest of South America Ophthalmol Drug Market Forecast (2017-2027)

10.2.5.      Middle East and Africa Ophthalmol Drug Market Forecast (2017-2027)

10.2.5.1. Saudi Arabia Ophthalmol Drug Market Forecast (2017-2027)

10.2.5.2. United Arab Emirates Ophthalmol Drug Market Forecast (2017-2027)

10.2.5.3. Egypt Ophthalmol Drug Market Forecast (2017-2027)

10.2.5.4. Nigeria Ophthalmol Drug Market Forecast (2017-2027)

10.2.5.5. South Africa Ophthalmol Drug Market Forecast (2017-2027)

10.2.5.6. Turkey Ophthalmol Drug Market Forecast (2017-2027)

10.2.5.7. Rest of Middle East and Africa Ophthalmol Drug Market Forecast (2017-2027)

10.3. Ophthalmol Drug Market Forecast by Ophthalmol Drug (2017-2027)

10.3.1.      Ophthalmol Drug Forecast by Ophthalmol Drug (2017-2027)

10.3.2.      Ophthalmol Drug Market Share Forecast by Ophthalmol Drug (2017-2027)

10.4. Ophthalmol Drug Market Forecast by End-User  (2017-2027)

10.4.1.      Ophthalmol Drug Forecast by End-User  (2017-2027)

10.4.2.      Ophthalmol Drug Market Share Forecast by End-User  (2017-2027)

List of Tables

List of Tables and Figures:

Figure United States Ophthalmol Drug Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Ophthalmol Drug Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Ophthalmol Drug Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Ophthalmol Drug Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Ophthalmol Drug Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Ophthalmol Drug Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Ophthalmol Drug Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Ophthalmol Drug Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Ophthalmol Drug Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Ophthalmol Drug Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Ophthalmol Drug Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Ophthalmol Drug Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Ophthalmol Drug Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Ophthalmol Drug Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Ophthalmol Drug Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Ophthalmol Drug Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Ophthalmol Drug Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Ophthalmol Drug Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Ophthalmol Drug Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Ophthalmol Drug Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Ophthalmol Drug Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Ophthalmol Drug Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Ophthalmol Drug Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Ophthalmol Drug Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Ophthalmol Drug Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Ophthalmol Drug Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Ophthalmol Drug Revenue and Revenue Share by Ophthalmol Drug (2017-2018)
Figure Global Dry eye drugs Revenue and Growth Rate (2017-2018)
Figure Global Retinal disorders drugs Revenue and Growth Rate (2017-2018)
Figure Global Glaucoma drugs and Allergic Revenue and Growth Rate (2017-2018)
Figure Global Inflammatory & Infective drugs Revenue and Growth Rate (2017-2018)
Table Global Ophthalmol Drug Revenue and Revenue Share by End-User (2017-2018)
Figure Global Retinal diseases Revenue and Growth Rate (2017-2018)
Figure Global Glaucoma Revenue and Growth Rate (2017-2018)
Figure Global Dry eye syndrome Revenue and Growth Rate (2017-2018)
Figure Global Other ophthalmic indications Revenue and Growth Rate (2017-2018)
Table Global Ophthalmol Drug Revenue by Regions (2017-2018)
Figure North America Ophthalmol Drug Growth Rate (2017-2018)
Figure North America Ophthalmol Drug Revenue and Growth Rate (2017-2018)
Figure North America Ophthalmol Drug by Countries (2017-2018)
Figure North America Ophthalmol Drug Revenue (Million USD) by Countries (2017-2018)
Figure United States Ophthalmol Drug Growth Rate (2017-2018)
Figure United States Ophthalmol Drug Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Ophthalmol Drug Growth Rate (2017-2018)
Figure Canada Ophthalmol Drug Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Ophthalmol Drug Growth Rate (2017-2018)
Figure Mexico Ophthalmol Drug Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Ophthalmol Drug Growth Rate (2017-2018)
Figure Europe Ophthalmol Drug Revenue and Growth Rate (2017-2018)
Figure Europe Ophthalmol Drug by Countries (2017-2018)
Figure Europe Ophthalmol Drug Revenue (Million USD) by Countries (2017-2018)
Figure Germany Ophthalmol Drug Growth Rate (2017-2018)
Figure Germany Ophthalmol Drug Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Ophthalmol Drug Growth Rate (2017-2018)
Figure France Ophthalmol Drug Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Ophthalmol Drug Growth Rate (2017-2018)
Figure UK Ophthalmol Drug Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Ophthalmol Drug Growth Rate (2017-2018)
Figure Russia Ophthalmol Drug Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Ophthalmol Drug Growth Rate (2017-2018)
Figure Italy Ophthalmol Drug Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Ophthalmol Drug Growth Rate (2017-2018)
Figure Rest of Europe Ophthalmol Drug Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Ophthalmol Drug Growth Rate (2017-2018)
Figure Asia-Pacific Ophthalmol Drug Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Ophthalmol Drug by Countries (2017-2018)
Figure Asia-Pacific Ophthalmol Drug Revenue (Million USD) by Countries (2017-2018)
Figure China Ophthalmol Drug Growth Rate (2017-2018)
Figure China Ophthalmol Drug Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Ophthalmol Drug Growth Rate (2017-2018)
Figure Japan Ophthalmol Drug Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Ophthalmol Drug Growth Rate (2017-2018)
Figure Korea Ophthalmol Drug Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Ophthalmol Drug Growth Rate (2017-2018)
Figure India Ophthalmol Drug Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Ophthalmol Drug Growth Rate (2017-2018)
Figure Southeast Asia Ophthalmol Drug Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Ophthalmol Drug Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Ophthalmol Drug Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Ophthalmol Drug Growth Rate (2017-2018)
Figure South America Ophthalmol Drug Revenue and Growth Rate (2017-2018)
Figure South America Ophthalmol Drug by Countries (2017-2018)
Figure South America Ophthalmol Drug Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Ophthalmol Drug Growth Rate (2017-2018)
Figure Brazil Ophthalmol Drug Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Ophthalmol Drug Growth Rate (2017-2018)
Figure Argentina Ophthalmol Drug Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Ophthalmol Drug Growth Rate (2017-2018)
Figure Columbia Ophthalmol Drug Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Ophthalmol Drug Growth Rate (2017-2018)
Figure Rest of South America Ophthalmol Drug Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Ophthalmol Drug Growth Rate (2017-2018)
Figure Middle East and Africa Ophthalmol Drug Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Ophthalmol Drug by Countries (2017-2018)
Figure Middle East and Africa Ophthalmol Drug Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Ophthalmol Drug Growth Rate (2017-2018)
Figure Saudi Arabia Ophthalmol Drug Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Ophthalmol Drug Growth Rate (2017-2018)
Figure United Arab Emirates Ophthalmol Drug Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Ophthalmol Drug Growth Rate (2017-2018)
Figure Egypt Ophthalmol Drug Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Ophthalmol Drug Growth Rate (2017-2018)
Figure Nigeria Ophthalmol Drug Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Ophthalmol Drug Growth Rate (2017-2018)
Figure South Africa Ophthalmol Drug Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Ophthalmol Drug Growth Rate (2017-2018)
Figure Turkey Ophthalmol Drug Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Ophthalmol Drug Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Ophthalmol Drug Revenue (Millions USD) and Growth Rate (2017-2018)
Table Akorn Ophthalmol Drug Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Roche Ophthalmol Drug Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Regeneron Ophthalmol Drug Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Novartis Ophthalmol Drug Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Senju Ophthalmol Drug Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Allergan Ophthalmol Drug Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Valeant Ophthalmol Drug Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Pfizer Ophthalmol Drug Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Bayer Ophthalmol Drug Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Santen Ophthalmol Drug Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Ophthalmol Drug Market Share by Manufacturer
Figure Global Ophthalmol Drug Revenue and Market Share by Manufacturer
Table Global Ophthalmol Drug Price by Region (2017-2017)
Figure Top 5 Ophthalmol Drug Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Ophthalmol Drug Revenue (Millions USD) and Growth Rate (2018-2025)
Table Ophthalmol Drug Market Forecast by Regions (2018-2025)
Figure North America Ophthalmol Drug Market Forecast (2018-2025)
Figure United States Ophthalmol Drug Market Forecast (2018-2025)
Figure Canada Ophthalmol Drug Market Forecast (2018-2025)
Figure Mexico Ophthalmol Drug Market Forecast (2018-2025)
Figure Europe Ophthalmol Drug Market Forecast (2018-2025)
Figure Germany Ophthalmol Drug Market Forecast (2018-2025)
Figure France Ophthalmol Drug Market Forecast (2018-2025)
Figure UK Ophthalmol Drug Market Forecast (2018-2025)
Figure Russia Ophthalmol Drug Market Forecast (2018-2025)
Figure Italy Ophthalmol Drug Market Forecast (2018-2025)
Figure Rest of Europe Ophthalmol Drug Market Forecast (2018-2025)
Figure Asia-Pacific Ophthalmol Drug Market Forecast (2018-2025)
Figure China Ophthalmol Drug Market Forecast (2018-2025)
Figure Japan Ophthalmol Drug Market Forecast (2018-2025)
Figure Korea Ophthalmol Drug Market Forecast (2018-2025)
Figure India Ophthalmol Drug Market Forecast (2018-2025)
Figure Southeast Asia Ophthalmol Drug Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Ophthalmol Drug Market Forecast (2018-2025)
Figure South America Ophthalmol Drug Market Forecast (2018-2025)
Figure Brazil Ophthalmol Drug Market Forecast (2018-2025)
Figure Argentina Ophthalmol Drug Market Forecast (2018-2025)
Figure Columbia Ophthalmol Drug Market Forecast (2018-2025)
Figure Rest of South America Ophthalmol Drug Market Forecast (2018-2025)
Figure Middle East and Africa Ophthalmol Drug Market Forecast (2018-2025)
Figure Saudi Arabia Ophthalmol Drug Market Forecast (2018-2025)
Figure United Arab Emirates Ophthalmol Drug Market Forecast (2018-2025)
Figure Egypt Ophthalmol Drug Market Forecast (2018-2025)
Figure Nigeria Ophthalmol Drug Market Forecast (2018-2025)
Figure South Africa Ophthalmol Drug Market Forecast (2018-2025)
Figure Turkey Ophthalmol Drug Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Ophthalmol Drug Market Forecast (2018-2025)
Figure Global Ophthalmol Drug Forecast by Ophthalmol Drug (2018-2025)
Figure Global Ophthalmol Drug Market Share Forecast by Ophthalmol Drug (2018-2025)
Figure Global Ophthalmol Drug Forecast by Ophthalmol Drug (2018-2025)
Figure Global Ophthalmol Drug Forecast by End-User (2018-2025)
Figure Global Ophthalmol Drug Market Share Forecast by End-User (2018-2025)
Figure Global Ophthalmol Drug Forecast by End-User (2018-2025)

Please Note: Data related to the Companies are subject to Availability.

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources
  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources
  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)
  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

Request Sample Enquire Before Buying Request for Customization

Request Sample